Trial Profile
Investigator Centers Will Be All French Hematology Centers Performing Autologous Transplantation and Prescribing Mozobil in Hematopoietic Stem Cell Mobilization Willing to Participate In This Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Therapeutic Use
- Sponsors Genzyme Corporation
- 30 Apr 2015 New trial record